Becton, Dickinson's BD Diagnostics Launches ProbeTec Trichomonas Vaginalis Q(x) Assay on Viper System

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today the U.S. Food and Drug Administration clearance and launch of the BD ProbeTec™ Trichomonas vaginalis Q^x Amplified DNA Assay for the direct qualitative detection of T. vaginalis DNA in endocervical and vaginal samples